Interestingly, while sgRNAs targeting SIK2 were enriched in our CRISPR/Cas9 kinome screen, sgRNAs for other LKB1 downstream targets were not (Dataset EV1), thereby suggesting that in uveal melanoma, LKB1 operates through SIK2 regulation. This evidence concerns the gene STK11 and uveal melanoma.